Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-16518

Xla.wt + dab2 MO, Shang N et al. (2020)

Experiment + Assay: Xla.wt + dab2 MO + NF31
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection dab2 MO3 dab2 (Xla)
 NF stage 2 (2-cell) blastomere
morpholino injection dab2 MO4 dab2 (Xla)
 NF stage 2 (2-cell) blastomere
Expression Phenotypes (9):
decreased amount actn4.L expression in myotome
decreased amount mef2c.L expression in myotome
decreased amount myf5.L expression in dermomyotome
decreased amount myf5.L expression in hyoid arch
decreased amount myf5.L expression in hypaxial muscle
decreased amount myod1.L expression in myotome
decreased amount myos.L expression in myotome
decreased amount pax3.L expression in hypaxial muscle
decreased amount pax3.L expression in myotome
Source: Fig. 9 b-l
Article: XB-ART-57124, PubMed